Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Mon, 03.03.2025
HBM Healthcare Investments AG
HBM Healthcare Investments AG
/ Key word(s): Monthly Figures
Key Figures
28.02.2025
03.03.2025 / 17:46 CET/CEST
in CHF
Performance in %
28.02.2025
MTD
FYTD
CYTD
NAV
242.55
-2.4
0.8
[ … ]
Mon, 03.03.2025
Alzchem Group AG
EQS-Media / 03.03.2025 / 17:12 CET/CEST
Alzchem Group invites you to the Creatine Conference 2025: Munich is becoming a hotspot for creatine research
The Alzchem Group is once again bringing together the brightest minds in creatine research in 2025 – in the heart of Munich. From March 12 to 15, 2025, the Meliá Hotel will be transformed into a [ … ]
Mon, 03.03.2025
Eleving Group S.A.
Riga, Latvia, 3 March 2025
On March 3, 2025, Eleving Group held an Investor Call, during which the Group’s CEO Modestas Sudnius and CFO Maris Kreics introduced everyone with the current public bond tap offering, shared insights into the Eleving Group’s recent financial performance and future plans, as well as answered call participants’ questions.T [ … ]
Mon, 03.03.2025
Delticom AG
Publication of inside information according to Article 17 of Regulation (EU) No. 596/2014
Delticom AG carries out a further share buyback program in the amount of up to 100,000 own shares
Hanover, March 03, 2025 – The Management Board of Delticom AG (“Company”) has decided to implement a further share buyback program, utilizing the authorization [ … ]
Mon, 03.03.2025
CENTROTEC SE
03.03.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
Mon, 03.03.2025
Pentixapharm Holding AG
Berlin, Germany, March 3, 2025 - Several previously announced personnel changes in the governing bodies of the Pentixapharm Group have taken effect as of March 1, 2025. The Management Board of the parent company Pentixapharm Holding AG is now identical in composition to the Management Board of the wholly owned operational subsidiary Pentixapharm AG [ … ]
Mon, 03.03.2025
Mainz BioMed N.V.
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
BERKELEY, US and MAINZ, Germany – March 3, 2025 - Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is proud to support Colorectal Cancer Awarenes [ … ]
Mon, 03.03.2025
Formycon AG
Press Release // March 3, 2025
FYB202/Otulfi ® (ustekinumab-aauz), a biosimilar to Stelara®, launched in the United States and the European Union
FYB202/Otulfi ® is now commercially available in both subcutaneous and intravenous formulations in the United States and the European Union
Patient transition to Otulfi® supported by comparable effic [ … ]
Mon, 03.03.2025
DeFi Technologies Inc.
Toronto, Canada, March 3, 2025 - DeFi Technologies Inc. (the “Company” or “DeFi Technologies”) (CBOE CA: DEFI) (GR: R9B) (OTC: DEFTF), a financial technology company that pioneers the convergence of traditional capital markets with the world of decentralised finance (“DeFi”), is pleased to announce the appointment of Chase Ergen to its board of dir [ … ]
Mon, 03.03.2025
ZEAL Network SE
Andrea Behrendt to become CFO at ZEAL from April 1, 2025
Board member Sebastian Bielski leaves the company at his own request as of March 31, 2025
Andrea Behrendt, currently VP Group Controlling & Portfolio Management at ZEAL, will take over the areas of finance, investor relations and all ESG issues on the Management Board
Hamburg, 03 [ … ]